For the latest COVID-19 campus news and resources, visit umassmed.edu/coronavirus.
By interweaving nucleic acid scientists with clinicians dedicated to finding new cures, our goal is to create a new paradigm for organizing molecular research that enables the rapid application of new biological discoveries to solutions for unmet challenges in human health.
Anastasia Khvorova, PhD, professor of RNA therapeutics, was elected to the National Academy of Inventors Fellows Class of 2022! The new class is comprised of 169 prolific academic innovators from over 110 research universities and research institutes worldwide. Read more.
Save the dates for June 21-23, 2023 for the 5th annual RNA Therapeutics Symposium. Inclusivity and family support awards are available!
ScienceLIVE is an educational science outreach program for Worcester area middle schools. We provide opportunities for students to engage with our diverse postdoctoral and graduate student trainees through interactive, exciting virtual and hands-on STEM activities.
Work from the Sontheimer and Xue labs showcase a compact base editor that enables efficient in vivo delivery using a single adeno-associated virus (AAV) vector. The innovation, once approved in clinical trials, could lower the doses of AAV vector needed to achieve therapeutic efficacy and bolster precision medicine approaches using somatic genome editing by making them faster and safer. See more at GEN Biotechnology on the​​ ​​Adenine Base Editing In Vivo with a Single Adeno-Associated Virus Vector​.
Meet Craig Mello, part of the RTI at UMass Chan, who was awarded the 2006 Nobel Prize in Physiology or Medicine, with Andrew Z. Fire, for the discovery of RNA interference. The discovery of RNAi has given scientists unprecedented opportunities to develop new life-saving therapies and advance our basic understanding of biology.
Worcester, known as the “Heart of the Commonwealth” is located in Central Massachusetts
